Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

A trial of complement inhibition in a patient with cryoglobulin-induced glomerulonephritis.

Hirt-Minkowski P, Trendelenburg M, Gröschl I, Fischer A, Heijnen I, Schifferli JA.

Case Rep Nephrol Urol. 2012 Jan;2(1):38-45. doi: 10.1159/000339403. Epub 2012 May 31.

2.

The role of complement in cryoglobulin-induced immune complex glomerulonephritis.

Trendelenburg M, Fossati-Jimack L, Cortes-Hernandez J, Turnberg D, Lewis M, Izui S, Cook HT, Botto M.

J Immunol. 2005 Nov 15;175(10):6909-14.

3.
4.

[Role of complement in experimental glomerulonephritis].

Parra Borges G, Mosquera J, Rodríguez-Iturbe B.

Invest Clin. 1991;32(2):91-105. Review. Spanish.

PMID:
1807401
5.

Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis.

Mühlfeld AS, Segerer S, Hudkins K, Farr AG, Bao L, Kraus D, Holers VM, Quigg RJ, Alpers CE.

Kidney Int. 2004 Apr;65(4):1214-23.

6.

Heat-insoluble cryoglobulin in a patient with essential type II cryoglobulinemia and cryoglobulin-occlusive membranoproliferative glomerulonephritis: case report and literature review.

Meng QH, Chibbar R, Pearson D, Kappel J, Krahn J.

Clin Chim Acta. 2009 Aug;406(1-2):170-3. doi: 10.1016/j.cca.2009.05.013. Epub 2009 May 20. Review.

PMID:
19463798
7.

Type II essential mixed cryoglobulinaemia: presentation, treatment and outcome in 13 patients.

Frankel AH, Singer DR, Winearls CG, Evans DJ, Rees AJ, Pusey CD.

Q J Med. 1992 Feb;82(298):101-24.

PMID:
1620812
8.

Heat-insoluble cryoglobulin in a patient with essential type I cryoglobulinemia and massive cryoglobulin-occlusive glomerulonephritis.

Ishimura E, Nishizawa Y, Shoji S, Okumura M, Nishitani H, Kim CW, Watanabe Y, Wakasa K, Morii H, Kashgarian M.

Am J Kidney Dis. 1995 Oct;26(4):654-7.

PMID:
7573022
10.

Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis.

Roberts JL, Wyatt RJ, Schwartz MM, Lewis EJ.

Clin Immunol Immunopathol. 1983 Nov;29(2):223-41.

PMID:
6605223
11.

Role of neutrophils in murine cryoglobulinemia.

Izui S, Fulpius T, Reininger L, Pastore Y, Kobayakawa T.

Inflamm Res. 1998 Oct;47 Suppl 3:S145-50.

PMID:
9831317
12.

Electron microscopy study of genesis and dynamics of immunodeposition in IgMk-IgG cryoglobulin-induced glomerulonephritis in mice.

Fornasieri A, Tazzari S, Li M, Armelloni S, Tarelli LT, Sessa A, D'Amico G.

Am J Kidney Dis. 1998 Mar;31(3):435-42.

PMID:
9506680
13.

Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.

De Vries B, Matthijsen RA, Wolfs TG, Van Bijnen AA, Heeringa P, Buurman WA.

Transplantation. 2003 Feb 15;75(3):375-82.

PMID:
12589162
14.

Renal involvement in monoclonal (type I) cryoglobulinemia: two cases associated with IgG3 kappa cryoglobulin.

Karras A, Noël LH, Droz D, Delansorne D, Saint-André JP, Aucouturier P, Alyanakian MA, Grünfeld JP, Lesavre P.

Am J Kidney Dis. 2002 Nov;40(5):1091-6. Review.

PMID:
12407656
15.
16.

Pathogenesis of glomerular damage in glomerulonephritis.

Couser WG.

Nephrol Dial Transplant. 1998;13 Suppl 1:10-5. Review.

PMID:
9507491
17.

Case of membranoproliferative glomerulonephritis due to essential cryoglobulinemia without hepatitis C virus infection.

Okura T, Jotoku M, Miyoshi K, Enomoto D, Kurata M, Irita J, Nagao T, Ohtsuka T, Higaki J.

Geriatr Gerontol Int. 2009 Mar;9(1):92-6. doi: 10.1111/j.1447-0594.2008.00493.x.

PMID:
19260986
18.
19.

Membranoproliferative glomerulonephritis in dogs with a genetically determined deficiency of the third component of complement.

Cork LC, Morris JM, Olson JL, Krakowka S, Swift AJ, Winkelstein JA.

Clin Immunol Immunopathol. 1991 Sep;60(3):455-70.

PMID:
1864020
20.

Supplemental Content

Support Center